View More Recent Stories

Mar 2, 2021 07:00AM Humanigen Expands its anti-GM-CSF Patent Portfolio
Feb 25, 2021 07:30AM Humanigen to Present at Multiple Investor Conferences in March
Feb 11, 2021 07:30AM Humanigen to Present and Participate at Multiple Upcoming Investor and Industry Conferences
Feb 8, 2021 07:16AM Humanigen Inc. (HGEN) Reports Election of Dr. Dale Chappell to Board
Feb 8, 2021 07:00AM Humanigen Elects Dr. Dale Chappell to Board of Directors
Feb 3, 2021 07:11AM Humanigen (HGEN) and Avid Bioservices (CDMO) Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing
Feb 3, 2021 07:00AM Humanigen and Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing
Feb 3, 2021 07:00AM Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing
Jan 29, 2021 07:12AM Humanigen Inc. (HGEN) Reports Complete Enrollment in Phase 3 Study of Lenzilumab in Hospitalized Patients with COVID-19
Jan 29, 2021 07:00AM Humanigen Completes Enrollment in Phase 3 Study of Lenzilumab in Hospitalized Patients with COVID-19
Jan 27, 2021 07:00AM Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study
Jan 27, 2021 07:00AM Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study
Jan 25, 2021 08:30AM Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™
Jan 22, 2021 07:02AM Humanigen Inc. (HGEN) Announces Addition of BARDA and Expansion of CRADA with U.S. Government to Develop Lenzilumab for COVID-19
Jan 22, 2021 07:00AM Humanigen Announces the Addition of BARDA and Expansion of CRADA with the U.S. Government to Develop Lenzilumab for COVID-19
Jan 10, 2021 08:00AM Humanigen and EVERSANA Announce Partnership to Support the Launch and Commercialization of Lenzilumab for the Treatment of COVID-19
Oct 21, 2020 09:27AM Pre-Open Stock Movers 10/21: (ASTC) (SNAP) (CALX) Higher; (GSX) (NAVI) (NFLX) Lower (more...)
Oct 20, 2020 05:33PM After-Hours Stock Movers 10/20: (ASTC) (SNAP) (PRTA) Higher; (NAVI) (NFLX) (APTX) Lower (more...)
View More Recent Stories